Condition
Locally Advanced Prostate Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Locally Advanced Prostate Cancer clinical trials that are recruiting, at sites in 3 countries (most in China (3), United States (2), Denmark (1)). By phase: Phase 2 (2), Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Locally Advanced Prostate Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Targeted tumor boost and shortened radiation schedules for prostate cancer | — | Aarhus and 2 other locations | Recruiting | Jan 15, 2026 |
| Improved robotic surgery for advanced prostate cancer | — | Fuzhou, Fujian | Recruiting | May 18, 2025 |
| Combining Pluvicto with radiation therapy for advanced prostate cancer | Phase 1/2 | Cleveland, Ohio | Recruiting | Aug 28, 2024 |
| Genomic biomarker-guided therapy for advanced prostate cancer | Phase 2 | Xiamen, Fujian | Recruiting | Apr 26, 2024 |
| Combining relugolix and enzalutamide for high-risk prostate cancer treatment | Phase 1 | Oklahoma City, Oklahoma | Recruiting | Nov 14, 2023 |
| Intense hormone therapy before surgery for advanced prostate cancer | Phase 2 | Nanjing, Jiangsu | Recruiting | Jun 7, 2022 |
All recruiting trials (6)
-
Targeted tumor boost and shortened radiation schedules for prostate cancer
This trial tests whether giving a higher radiation dose to the tumor inside the prostate (a focal boost) and delivering treatment in 12 instead of 20 sessions helps men with intermediate- or high-risk prostate cancer have fewer relapses and need less hormonal therapy.
-
Improved robotic surgery for advanced prostate cancer
This study tests a new robotic surgery technique for advanced prostate cancer to see if it helps improve recovery and urinary control compared to standard methods.
-
Combining Pluvicto with radiation therapy for advanced prostate cancer
This study is testing if combining the drug Pluvicto with radiation therapy can help people with advanced prostate cancer reduce the chance of their cancer coming back while keeping their quality of life intact.
-
Genomic biomarker-guided therapy for advanced prostate cancer
This study is testing if personalized treatment based on genetic markers can help men with advanced prostate cancer before surgery.
-
Combining relugolix and enzalutamide for high-risk prostate cancer treatment
This study is testing if combining two medications, relugolix and enzalutamide, can help men with high-risk prostate cancer do better with their treatment and live longer.
-
Intense hormone therapy before surgery for advanced prostate cancer
This study is testing whether a stronger hormone treatment before surgery can help men with advanced prostate cancer do better than the usual hormone therapy.
Related topics
Quick answers
How many Locally Advanced Prostate Cancer clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), United States (2 trials), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.